Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphataemia Receiving Hemodialysis

NCT01901107 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT01901107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01901107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphataemia Receiving Hemodialysis
Lead sponsor
Astellas Pharma Inc
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
December 31, 2016
Enrollment
1,078 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

chronic renal failure patients with hyperphosphataemia receiving hemodialysis